TY - JOUR AU - Bolton-Maggs, P. H. AU - Cohen, H. PY - 2013 DA - 2013// TI - Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety JO - Br J Haematol. VL - 163 UR - https://doi.org/10.1111/bjh.12547 DO - 10.1111/bjh.12547 ID - Bolton-Maggs2013 ER - TY - JOUR AU - Kleinman, S. AU - Reed, W. AU - Stassinopoulos, A. PY - 2013 DA - 2013// TI - A patient-oriented risk-benefit analysis of pathogen-inactivated blood components: application to apheresis platelets in the United States JO - Transfusion VL - 53 UR - https://doi.org/10.1111/j.1537-2995.2012.03928.x DO - 10.1111/j.1537-2995.2012.03928.x ID - Kleinman2013 ER - TY - JOUR AU - Brecher, M. E. AU - Hay, S. N. PY - 2005 DA - 2005// TI - Bacterial contamination of blood components JO - Clin Microbiol Rev VL - 18 UR - https://doi.org/10.1128/CMR.18.1.195-204.2005 DO - 10.1128/CMR.18.1.195-204.2005 ID - Brecher2005 ER - TY - CHAP PY - 2016 DA - 2016// BT - Bacterial Risk Control Strategies for Blood Collection Establishments and Transfusion Services to Enhance the Safety and Availability of Platelets for Transfusion: Draft Guidance for Industry PB - US Food and Drug Administration CY - Silver Spring ID - ref4 ER - TY - JOUR AU - Engele, L. J. AU - Straat, M. AU - van Rooijen, I. H. M. AU - de Vooght, K. M. K. PY - 2016 DA - 2016// TI - Transfusion of platelets, but not of red blood cells, is independently associated with nosocomial infections in the critically ill JO - Ann Intensive Care VL - 6 UR - https://doi.org/10.1186/s13613-016-0173-1 DO - 10.1186/s13613-016-0173-1 ID - Engele2016 ER - TY - JOUR AU - Lieberman, L. AU - Bercovitz, R. S. AU - Sholapur, N. S. AU - Heddle, N. M. AU - Stanworth, S. J. AU - Arnold, D. M. PY - 2014 DA - 2014// TI - Platelet transfusions for critically ill patients with thrombocytopenia JO - Blood VL - 123 UR - https://doi.org/10.1182/blood-2013-02-435693 DO - 10.1182/blood-2013-02-435693 ID - Lieberman2014 ER - TY - JOUR AU - Lopez, D. AU - Vlamakis, H. AU - Kolter, R. PY - 2010 DA - 2010// TI - Biofilms JO - Cold Spring Harb Perspect Biol VL - 2 UR - https://doi.org/10.1101/cshperspect.a000398 DO - 10.1101/cshperspect.a000398 ID - Lopez2010 ER - TY - JOUR AU - Eder, A. F. AU - Dy, B. A. AU - DeMerse, B. AU - Wagner, S. J. AU - Stramer, S. L. AU - O’Neill, E. M. PY - 2017 DA - 2017// TI - Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions JO - Transfusion VL - 57 UR - https://doi.org/10.1111/trf.14308 DO - 10.1111/trf.14308 ID - Eder2017 ER - TY - JOUR AU - Aubron, C. AU - Flint, A. W. AU - Bailey, M. AU - Pilcher, D. AU - Cheng, A. C. AU - Hegarty, C. PY - 2017 DA - 2017// TI - Is platelet transfusion associated with hospital-acquired infections in critically ill patients? JO - Crit Care VL - 21 UR - https://doi.org/10.1186/s13054-016-1593-x DO - 10.1186/s13054-016-1593-x ID - Aubron2017 ER - TY - BOOK PY - 2013 DA - 2013// TI - Circular of Information for the Use of Human Blood and Blood Components PB - AABB CY - Bethesda ID - ref10 ER - TY - JOUR AU - Hong, H. AU - Xiao, W. AU - Lazarus, H. M. AU - Good, C. E. AU - Maitta, R. W. AU - Jacobs, M. R. PY - 2016 DA - 2016// TI - Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance JO - Blood VL - 127 UR - https://doi.org/10.1182/blood-2015-07-655944 DO - 10.1182/blood-2015-07-655944 ID - Hong2016 ER - TY - JOUR AU - Murphy, W. G. AU - Foley, M. AU - Doherty, C. AU - Tierney, G. AU - Kinsella, A. AU - Salami, A. PY - 2008 DA - 2008// TI - Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety JO - Vox Sang VL - 95 UR - https://doi.org/10.1111/j.1423-0410.2008.01051.x DO - 10.1111/j.1423-0410.2008.01051.x ID - Murphy2008 ER - TY - JOUR AU - Pearce, S. AU - Rowe, G. P. AU - Field, S. P. PY - 2011 DA - 2011// TI - Screening of platelets for bacterial contamination at the Welsh Blood Service JO - Transfus Med VL - 21 UR - https://doi.org/10.1111/j.1365-3148.2010.01037.x DO - 10.1111/j.1365-3148.2010.01037.x ID - Pearce2011 ER - TY - JOUR AU - Ning, S. AU - Barty, R. AU - Liu, Y. AU - Heddle, N. M. AU - Rochwerg, B. AU - Arnold, D. M. PY - 2016 DA - 2016// TI - Platelet Transfusion Practices in the ICU: Data From a Large Transfusion Registry JO - Chest VL - 150 UR - https://doi.org/10.1016/j.chest.2016.04.004 DO - 10.1016/j.chest.2016.04.004 ID - Ning2016 ER - TY - JOUR AU - Greinacher, A. AU - Selleng, S. PY - 2016 DA - 2016// TI - How I evaluate and treat thrombocytopenia in the intensive care unit patient JO - Blood VL - 128 ID - Greinacher2016 ER - TY - JOUR AU - Gershman, M. D. AU - Kennedy, D. J. AU - Noble-Wang, J. AU - Kim, C. AU - Gullion, J. AU - Kacica, M. PY - 2008 DA - 2008// TI - Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy JO - Clin Infect Dis VL - 47 UR - https://doi.org/10.1086/592968 DO - 10.1086/592968 ID - Gershman2008 ER - TY - JOUR AU - Taleghani, B. e. h. r. o. u. z. M. a. n. s. o. u. r. i. AU - Heuft, H. a. n. s. -. G. e. r. t. PY - 2014 DA - 2014// TI - Hemovigilance JO - Transfusion Medicine and Hemotherapy VL - 41 UR - https://doi.org/10.1159/000363597 DO - 10.1159/000363597 ID - Taleghani2014 ER - TY - JOUR AU - Hendrickson, J. E. AU - Roubinian, N. H. AU - Chowdhury, D. AU - Brambilla, D. AU - Murphy, E. L. AU - Wu, Y. PY - 2016 DA - 2016// TI - Incidence of transfusion reactions: a multicenter study utilizing systematic active surveillance and expert adjudication JO - Transfusion VL - 56 UR - https://doi.org/10.1111/trf.13730 DO - 10.1111/trf.13730 ID - Hendrickson2016 ER - TY - JOUR AU - Rollins, M. D. AU - Molofsky, A. B. AU - Nambiar, A. AU - Pandey, S. AU - Weiskopf, R. B. AU - Toy, P. PY - 2012 DA - 2012// TI - Two septic transfusion reactions presenting as transfusion-related acute lung injury from a split plateletpheresis unit JO - Crit Care Med VL - 40 UR - https://doi.org/10.1097/CCM.0b013e3182544f85 DO - 10.1097/CCM.0b013e3182544f85 ID - Rollins2012 ER - TY - JOUR AU - Horth, R. Z. AU - Jones, J. M. AU - Kim, J. J. AU - Lopansri, B. K. AU - Ilstrup, S. J. AU - Fridey, J. PY - 2018 DA - 2018// TI - Fatal Sepsis Associated with Bacterial Contamination of Platelets - Utah and California, August 2017 JO - MMWR Morb Mortal Wkly Rep VL - 67 UR - https://doi.org/10.15585/mmwr.mm6725a4 DO - 10.15585/mmwr.mm6725a4 ID - Horth2018 ER - TY - STD TI - FDA. Vaccines, Blood & Biologics. 2018 [cited 2018 Sept 8]. Available from: https://www.fda.gov/BiologicsBloodVaccines/default.htm. Accessed 10 Oct 2018. UR - https://www.fda.gov/BiologicsBloodVaccines/default.htm ID - ref21 ER - TY - BOOK PY - 2018 DA - 2018// TI - Standards for Blood Banks and Transfusion Services 31th Edition PB - AABB CY - Bethesda ID - ref22 ER - TY - JOUR AU - Grossman, B. J. AU - Kollins, P. AU - Lau, P. M. AU - Perreten, J. L. AU - Bowman, R. J. AU - Malcolm, S. PY - 1991 DA - 1991// TI - Screening blood donors for gastrointestinal illness: a strategy to eliminate carriers of Yersinia enterocolitica JO - Transfusion VL - 31 UR - https://doi.org/10.1046/j.1537-2995.1991.31691306245.x DO - 10.1046/j.1537-2995.1991.31691306245.x ID - Grossman1991 ER - TY - JOUR AU - de Korte, D. AU - Marcelis, J. H. PY - 2014 DA - 2014// TI - Platelet concentrates: reducing the risk of transfusion-transmitted bacterial infections JO - Int J Clin Transfus Med VL - 2 UR - https://doi.org/10.2147/IJCTM.S40037 DO - 10.2147/IJCTM.S40037 ID - de Korte2014 ER - TY - BOOK PY - 2012 DA - 2012// TI - US Food and Drug Administration. Blood Products Advisory Committee. 104th Meeting. Topic III: Considerations for options to further reduce the risk of bacterial contamination in platelets. US Food and Drug Administration ID - ref25 ER - TY - JOUR AU - Störmer, M. AU - Vollmer, T. PY - 2014 DA - 2014// TI - Diagnostic Methods for Platelet Bacteria Screening: Current Status and Developments JO - Transfus Med Hemother VL - 41 UR - https://doi.org/10.1159/000357651 DO - 10.1159/000357651 ID - Störmer2014 ER - TY - JOUR AU - Dunne, W. M. AU - Dunne, W. M. AU - Case, L. K. AU - Isgriggs, L. AU - Lublin, D. M. PY - 2005 DA - 2005// TI - In-house validation of the BACTEC 9240 blood culture system for detection of bacterial contamination in platelet concentrates JO - Transfusion VL - 45 UR - https://doi.org/10.1111/j.1537-2995.2005.04343.x DO - 10.1111/j.1537-2995.2005.04343.x ID - Dunne2005 ER - TY - JOUR AU - Mastronardi, C. AU - Perkins, H. AU - Derksen, P. AU - denAdmirant, M. AU - Ramírez-Arcos, S. PY - 2010 DA - 2010// TI - Evaluation of the BacT/ALERT 3D system for the implementation of in-house quality control sterility testing at Canadian Blood Services JO - Clin Chem Lab Med VL - 48 UR - https://doi.org/10.1515/CCLM.2010.240 DO - 10.1515/CCLM.2010.240 ID - Mastronardi2010 ER - TY - JOUR AU - Ramirez-Arcos, S. AU - DiFranco, C. AU - McIntyre, T. AU - Goldman, M. PY - 2017 DA - 2017// TI - Residual risk of bacterial contamination of platelets: six years of experience with sterility testing JO - Transfusion VL - 57 UR - https://doi.org/10.1111/trf.14202 DO - 10.1111/trf.14202 ID - Ramirez-Arcos2017 ER - TY - JOUR AU - Thyer, J. AU - Perkowska-Guse, Z. AU - Ismay, S. L. AU - Keller, A. J. AU - Chan, H. T. AU - Dennington, P. M. PY - 2018 DA - 2018// TI - Bacterial testing of platelets - has it prevented transfusion-transmitted bacterial infections in Australia? JO - Vox Sang VL - 113 UR - https://doi.org/10.1111/vox.12561 DO - 10.1111/vox.12561 ID - Thyer2018 ER - TY - JOUR AU - Kamel, H. AU - Townsend, M. AU - Bravo, M. AU - Vassallo, R. R. PY - 2017 DA - 2017// TI - Improved yield of minimal proportional sample volume platelet bacterial culture JO - Transfusion VL - 57 UR - https://doi.org/10.1111/trf.14198 DO - 10.1111/trf.14198 ID - Kamel2017 ER - TY - JOUR AU - Greco-Stewart, V. S. AU - Brown, E. E. AU - Parr, C. AU - Kalab, M. AU - Jacobs, M. R. AU - Yomtovian, R. A. PY - 2012 DA - 2012// TI - Serratia marcescens strains implicated in adverse transfusion reactions form biofilms in platelet concentrates and demonstrate reduced detection by automated culture JO - Vox Sang VL - 102 UR - https://doi.org/10.1111/j.1423-0410.2011.01550.x DO - 10.1111/j.1423-0410.2011.01550.x ID - Greco-Stewart2012 ER - TY - JOUR AU - Heaton, W. A. AU - Good, C. E. AU - Galloway-Haskins, R. AU - Yomtovian, R. A. AU - Jacobs, M. R. PY - 2014 DA - 2014// TI - Evaluation of a rapid colorimetric assay for detection of bacterial contamination in apheresis and pooled random-donor platelet units JO - Transfusion VL - 54 UR - https://doi.org/10.1111/trf.12603 DO - 10.1111/trf.12603 ID - Heaton2014 ER - TY - JOUR AU - Jacobs, M. R. AU - Smith, D. AU - Heaton, W. A. AU - Zantek, N. D. AU - Good, C. E. PY - 2011 DA - 2011// TI - Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test JO - Transfusion VL - 51 UR - https://doi.org/10.1111/j.1537-2995.2011.03308.x DO - 10.1111/j.1537-2995.2011.03308.x ID - Jacobs2011 ER - TY - JOUR AU - Vollmer, T. AU - Hinse, D. AU - Kleesiek, K. AU - Dreier, J. PY - 2010 DA - 2010// TI - The Pan Genera Detection immunoassay: a novel point-of-issue method for detection of bacterial contamination in platelet concentrates JO - J Clin Microbiol VL - 48 UR - https://doi.org/10.1128/JCM.00542-10 DO - 10.1128/JCM.00542-10 ID - Vollmer2010 ER - TY - STD TI - Platelet PGD® Test [Package Insert]. Marlborough: Verax Biomedical; 2017. http://veraxbiomedical.com/wp-content/uploads/2018/01/US_Platelet_PGD_Test.pdf (Accessed 10/10/18). UR - http://veraxbiomedical.com/wp-content/uploads/2018/01/US_Platelet_PGD_Test.pdf ID - ref36 ER - TY - JOUR AU - Janssen, M. P. AU - van der Poel, C. L. AU - Buskens, E. AU - Bonneux, L. AU - Bonsel, G. J. AU - van Hout, B. A. PY - 2006 DA - 2006// TI - Costs and benefits of bacterial culturing and pathogen reduction in the Netherlands JO - Transfusion VL - 46 UR - https://doi.org/10.1111/j.1537-2995.2006.00828.x DO - 10.1111/j.1537-2995.2006.00828.x ID - Janssen2006 ER - TY - JOUR AU - Li, J. W. AU - Brecher, M. E. AU - Jacobson, J. L. AU - Harm, S. K. AU - Chen, D. AU - El-Gamil, A. PY - 2017 DA - 2017// TI - Addressing the risk of bacterial contamination in platelets: a hospital economic perspective JO - Transfusion VL - 57 UR - https://doi.org/10.1111/trf.14216 DO - 10.1111/trf.14216 ID - Li2017 ER - TY - JOUR AU - Bell, C. E. AU - Botteman, M. F. AU - Gao, X. AU - Weissfeld, J. L. AU - Postma, M. J. AU - Pashos, C. L. PY - 2003 DA - 2003// TI - Cost-effectiveness of transfusion of platelet components prepared with pathogen inactivation treatment in the United States JO - Clin Ther VL - 25 UR - https://doi.org/10.1016/S0149-2918(03)80288-6 DO - 10.1016/S0149-2918(03)80288-6 ID - Bell2003 ER - TY - JOUR AU - Moeremans, K. AU - Warie, H. AU - Annemans, L. PY - 2006 DA - 2006// TI - Assessment of the economic value of the INTERCEPT blood system in Belgium JO - Transfus Med VL - 16 UR - https://doi.org/10.1111/j.1365-3148.2006.00644.x DO - 10.1111/j.1365-3148.2006.00644.x ID - Moeremans2006 ER - TY - JOUR AU - Benjamin, R. J. AU - Braschler, T. AU - Weingand, T. AU - Corash, L. M. PY - 2017 DA - 2017// TI - Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems JO - Transfusion VL - 57 UR - https://doi.org/10.1111/trf.14284 DO - 10.1111/trf.14284 ID - Benjamin2017 ER - TY - JOUR AU - Mundt, J. M. AU - Rouse, L. AU - Van den Bossche, J. AU - Goodrich, R. P. PY - 2014 DA - 2014// TI - Chemical and biological mechanisms of pathogen reduction technologies JO - Photochem Photobiol VL - 90 ID - Mundt2014 ER - TY - JOUR AU - Prowse, C. V. PY - 2013 DA - 2013// TI - Component pathogen inactivation: a critical review JO - Vox Sang VL - 104 UR - https://doi.org/10.1111/j.1423-0410.2012.01662.x DO - 10.1111/j.1423-0410.2012.01662.x ID - Prowse2013 ER - TY - JOUR AU - Schlenke, P. PY - 2014 DA - 2014// TI - Pathogen inactivation technologies for cellular blood components: an update JO - Transfus Med Hemother VL - 41 UR - https://doi.org/10.1159/000365646 DO - 10.1159/000365646 ID - Schlenke2014 ER - TY - JOUR AU - Irsch, J. AU - Lin L. PY - 2011 DA - 2011// TI - Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System JO - Transfus Med Hemother VL - 38 UR - https://doi.org/10.1159/000323937 DO - 10.1159/000323937 ID - Irsch2011 ER - TY - JOUR AU - Lin, L. AU - Dikeman, R. AU - Molini, B. AU - Lukehart, S. A. AU - Lane, R. AU - Dupuis, K. PY - 2004 DA - 2004// TI - Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria JO - Transfusion VL - 44 UR - https://doi.org/10.1111/j.1537-2995.2004.04125.x DO - 10.1111/j.1537-2995.2004.04125.x ID - Lin2004 ER - TY - JOUR AU - Lin, L. AU - Hanson, C. V. AU - Alter, H. J. AU - Jauvin, V. AU - Bernard, K. A. AU - Murthy, K. K. PY - 2005 DA - 2005// TI - Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light JO - Transfusion VL - 45 UR - https://doi.org/10.1111/j.0041-1132.2005.04316.x DO - 10.1111/j.0041-1132.2005.04316.x ID - Lin2005 ER - TY - JOUR AU - Corash, L. AU - Benjamin, R. J. PY - 2016 DA - 2016// TI - The role of hemovigilance and postmarketing studies when introducing innovation into transfusion medicine practice: the amotosalen-ultraviolet A pathogen reduction treatment model JO - Transfusion VL - 56 UR - https://doi.org/10.1111/trf.13530 DO - 10.1111/trf.13530 ID - Corash2016 ER - TY - JOUR AU - Lozano, M. AU - Knutson, F. AU - Tardivel, R. AU - Cid, J. AU - Maymó, R. M. AU - Löf, H. PY - 2011 DA - 2011// TI - A multi-centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion JO - Br J Haematol VL - 153 UR - https://doi.org/10.1111/j.1365-2141.2011.08635.x DO - 10.1111/j.1365-2141.2011.08635.x ID - Lozano2011 ER - TY - JOUR AU - McCullough, J. AU - Vesole, D. H. AU - Benjamin, R. J. AU - Slichter, S. J. AU - Pineda, A. AU - Snyder, E. PY - 2004 DA - 2004// TI - Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial JO - Blood VL - 104 UR - https://doi.org/10.1182/blood-2003-12-4443 DO - 10.1182/blood-2003-12-4443 ID - McCullough2004 ER - TY - JOUR AU - Knutson, F. AU - Osselaer, J. AU - Pierelli, L. AU - Lozano, M. AU - Cid, J. AU - Tardivel, R. PY - 2015 DA - 2015// TI - A prospective, active haemovigilance study with combined cohort analysis of 19,175 transfusions of platelet components prepared with amotosalen-UVA photochemical treatment JO - Vox Sang VL - 109 UR - https://doi.org/10.1111/vox.12287 DO - 10.1111/vox.12287 ID - Knutson2015 ER - TY - JOUR AU - Snyder, E. d. w. a. r. d. AU - McCullough, J. e. f. f. r. e. y. AU - Slichter, S. h. e. r. r. i. l. l. J. AU - Strauss, R. o. n. a. l. d. G. AU - Lopez-Plaza, I. l. e. a. n. a. AU - Lin, J. i. n. -. S. y. i. n. g. AU - Corash, L. a. u. r. e. n. c. e. AU - Conlan, M. a. u. r. e. e. n. G. PY - 2005 DA - 2005// TI - Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial JO - Transfusion VL - 45 UR - https://doi.org/10.1111/j.1537-2995.2005.00639.x DO - 10.1111/j.1537-2995.2005.00639.x ID - Snyder2005 ER - TY - JOUR AU - Amato, M. AU - Schennach, H. AU - Astl, M. AU - Chen, C. Y. AU - Lin, J. -. S. AU - Benjamin, R. J. PY - 2017 DA - 2017// TI - Impact of platelet pathogen inactivation on blood component utilization and patient safety in a large Austrian Regional Medical Centre JO - Vox Sang. VL - 112 UR - https://doi.org/10.1111/vox.12456 DO - 10.1111/vox.12456 ID - Amato2017 ER - TY - JOUR AU - Marschner, S. AU - Goodrich, R. PY - 2011 DA - 2011// TI - Pathogen reduction technology treatment of platelets, plasma and whole blood using riboflavin and UV light JO - Transfus Med Hemother. VL - 38 UR - https://doi.org/10.1159/000324160 DO - 10.1159/000324160 ID - Marschner2011 ER - TY - JOUR AU - Goodrich, R. P. AU - Gilmour, D. AU - Hovenga, N. AU - Keil, S. D. PY - 2009 DA - 2009// TI - A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns JO - Transfusion VL - 49 UR - https://doi.org/10.1111/j.1537-2995.2009.02126.x DO - 10.1111/j.1537-2995.2009.02126.x ID - Goodrich2009 ER - TY - JOUR AU - Taha, M. AU - Culibrk, B. AU - Kalab, M. AU - Schubert, P. AU - Yi, Q. L. AU - Goodrich, R. PY - 2017 DA - 2017// TI - Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm-derived Staphylococcus epidermidis in buffy coat platelet concentrates JO - Vox Sang VL - 112 UR - https://doi.org/10.1111/vox.12519 DO - 10.1111/vox.12519 ID - Taha2017 ER - TY - JOUR AU - Perez-Pujol, S. AU - Tonda, R. AU - Lozano, M. AU - Fuste, B. AU - Lopez-Vilchez, I. AU - Galan, A. M. PY - 2005 DA - 2005// TI - Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates JO - Transfusion VL - 45 UR - https://doi.org/10.1111/j.1537-2995.2005.04350.x DO - 10.1111/j.1537-2995.2005.04350.x ID - Perez-Pujol2005 ER - TY - JOUR PY - 2010 DA - 2010// TI - A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology JO - Transfusion VL - 50 UR - https://doi.org/10.1111/j.1537-2995.2010.02694.x DO - 10.1111/j.1537-2995.2010.02694.x ID - ref58 ER - TY - JOUR AU - Ignatova, A. A. AU - Karpova, O. V. AU - Trakhtman, P. E. AU - Rumiantsev, S. A. AU - Panteleev, M. A. PY - 2016 DA - 2016// TI - Functional characteristics and clinical effectiveness of platelet concentrates treated with riboflavin and ultraviolet light in plasma and in platelet additive solution JO - Vox Sang. VL - 110 UR - https://doi.org/10.1111/vox.12364 DO - 10.1111/vox.12364 ID - Ignatova2016 ER - TY - JOUR AU - Johnson, L. AU - Marks, D. PY - 2015 DA - 2015// TI - Treatment of platelet concentrates with the Mirasol pathogen inactivation system modulates platelet oxidative stress and NF-kappaB activation JO - Transfus Med Hemother VL - 42 UR - https://doi.org/10.1159/000403245 DO - 10.1159/000403245 ID - Johnson2015 ER - TY - JOUR AU - Seltsam, A. AU - Muller, T. H. PY - 2011 DA - 2011// TI - UVC Irradiation for Pathogen Reduction of Platelet Concentrates and Plasma JO - Transfus Med Hemother. VL - 38 UR - https://doi.org/10.1159/000323845 DO - 10.1159/000323845 ID - Seltsam2011 ER - TY - JOUR AU - Mohr, H. AU - Steil, L. AU - Gravemann, U. AU - Thiele, T. AU - Hammer, E. AU - Greinacher, A. PY - 2009 DA - 2009// TI - A novel approach to pathogen reduction in platelet concentrates using short-wave ultraviolet light JO - Transfusion VL - 49 UR - https://doi.org/10.1111/j.1537-2995.2009.02334.x DO - 10.1111/j.1537-2995.2009.02334.x ID - Mohr2009 ER - TY - JOUR AU - Faddy, H. M. AU - Faddy, H. M. AU - Fryk, J. J. AU - Prow, N. A. AU - Watterson, D. AU - Young, P. R. AU - Hall, R. A. PY - 2016 DA - 2016// TI - Inactivation of dengue, chikungunya, and Ross River viruses in platelet concentrates after treatment with ultraviolet C light JO - Transfusion VL - 56 UR - https://doi.org/10.1111/trf.13519 DO - 10.1111/trf.13519 ID - Faddy2016 ER - TY - JOUR AU - Sandgren, P. AU - Tolksdorf, F. AU - Struff, W. G. AU - Gulliksson, H. PY - 2011 DA - 2011// TI - In vitro effects on platelets irradiated with short-wave ultraviolet light without any additional photoactive reagent using the THERAFLEX UV-Platelets method JO - Vox Sang. VL - 101 UR - https://doi.org/10.1111/j.1423-0410.2010.01454.x DO - 10.1111/j.1423-0410.2010.01454.x ID - Sandgren2011 ER - TY - JOUR AU - Thiele, T. AU - Pohler, P. AU - Kohlmann, T. AU - Sümnig, A. AU - Aurich, K. AU - Selleng, K. PY - 2015 DA - 2015// TI - Tolerance of platelet concentrates treated with UVC-light only for pathogen reduction--a phase I clinical trial JO - Vox Sang. VL - 109 UR - https://doi.org/10.1111/vox.12247 DO - 10.1111/vox.12247 ID - Thiele2015 ER - TY - STD TI - AABB. AABB. Response to docket No. FDA-2014-D-1814 “Bacterial detection testing by blood and blood collection establishments and transfusion services to enhance the safety and availability of platelets for transfusion”. 2015 [cited December 2017 20 April]. Available from: http://www.aabb.org/advocacy/comments/Documents/comments150309.pdf. Accessed 10 Oct 2018. UR - http://www.aabb.org/advocacy/comments/Documents/comments150309.pdf ID - ref66 ER - TY - JOUR AU - Snyder, E. L. AU - Stramer, S. L. AU - Benjamin, R. J. PY - 2015 DA - 2015// TI - The safety of the blood supply--time to raise the bar JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMp1500154 DO - 10.1056/NEJMp1500154 ID - Snyder2015 ER - TY - JOUR AU - Drew, V. J. AU - Barro, L. AU - Seghatchian, J. AU - Burnouf, T. PY - 2017 DA - 2017// TI - Towards pathogen inactivation of red blood cells and whole blood targeting viral DNA/RNA: design, technologies, and future prospects for developing countries JO - Blood Transfus VL - 15 ID - Drew2017 ER - TY - STD TI - Giordano K. Pathogen-reduced (PR) cryoprecipitate stored for five days post thaw: apheresis source plasma yields more fibrinogen. SCA 39th Annual Meeting & Workshops, April 22–26 2017 [cited December 2017]. Available from: http://sca.planion.com/Web.User/AbstractDet?ACCOUNT=SCA&ABSID=20927&CONF=AM17&ssoOverride=OFF&CKEY. Accessed 10 Oct 2018. UR - http://sca.planion.com/Web.User/AbstractDet?ACCOUNT=SCA&ABSID=20927&CONF=AM17&ssoOverride=OFF&CKEY ID - ref69 ER - TY - JOUR AU - Spindler-Raffel, E. AU - Benjamin, R. J. AU - CP, M. D. AU - Ramirez-Arcos, S. AU - Aplin, K. AU - Bekeredjian-Ding, I. PY - 2017 DA - 2017// TI - Enlargement of the WHO international repository for platelet transfusion-relevant bacteria reference strains JO - Vox Sang VL - 112 UR - https://doi.org/10.1111/vox.12548 DO - 10.1111/vox.12548 ID - Spindler-Raffel2017 ER -